Amgen and Humana reported positive Earnings Stock Purchase Plan (ESP) figures as of July 17, 2025.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen and Humana reported positive Earnings Stock Purchase Plan (ESP) figures as of July 17, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Amgen and Merck are currently competing against each other in the market for investor capital.
- Amgen Inc. trades on the NASDAQ stock exchange.
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- Both Amdocs and Amgen are currently subject to analyst reviews.
Coverage
Newest first; wire copies grouped- ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they